Business Trends

Jul 01, 2018
BioPharm International
After 30 years of biologic-drug advances, the industry and patients still have a lot to learn.
Jul 01, 2018
BioPharm International
This article highlights 15 years of changes in biopharmaceutical manufacturing.
Jun 26, 2018
By BioPharm International Editors
Strategic restructuring is designed to position GE Healthcare as a pure-play healthcare company.
Jun 25, 2018
By BioPharm International Editors
GW Research’s Epidiolex, which treats two forms of epilepsy, receives FDA’s approval; spurs FDA reminders about unapproved products.
Jun 07, 2018
By BioPharm International Editors
A new report released at the BIO International Convention shows that the US bioscience industry has had a $2-trillion economic impact and has accelerated venture capital investment and job growth.
Jun 01, 2018
BioPharm International
By minding gaps in industry knowledge, bio/pharma companies can avoid development pitfalls.
Jun 01, 2018
By BioPharm International Editors
Madison Dearborn Partners will acquire a majority ownership position in CDMO Alcami.
Jun 01, 2018
By BioPharm International Editors
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
May 14, 2018
By BioPharm International Editors
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
May 09, 2018
By BioPharm International Editors
Takeda expands its global and therapy base with announced acquisition of Shire.
native1_300x100
lorem ipsum